STAT3 mRNA and protein expression in colorectal cancer: effects on STAT3-inducible targets linked to cell survival and proliferation - PubMed (original) (raw)
STAT3 mRNA and protein expression in colorectal cancer: effects on STAT3-inducible targets linked to cell survival and proliferation
Silke Lassmann et al. J Clin Pathol. 2007 Feb.
Abstract
Aims: To evaluate mRNA and protein expression of signal transducers and activators of transcription (STAT)3 in colorectal carcinomas (CRCs) and to define the association of STAT3 activity with the STAT3-inducible targets cyclin D1, survivin, Bcl-xl and Mcl-1.
Materials and methods: Matching serial sections of normal colonic epithelium and invasive CRCs (n = 32) were subjected to quantitative reverse transcriptase polymerase chain reaction specific to STAT3, cyclin D1, survivin, Bcl-xl and Mcl-1, as well as immunohistochemistry. For STAT3 immunohistochemistry, two antibodies, recognising unphosphorylated (UP-) and phosphorylated (tyr705, P-) STAT3 were used. Ki-67 (MIB-1) staining was included as a proliferation marker.
Results: Compared with normal colonic epithelium, UP-STAT3 and P-STAT3 (p = 0.023 and 0.006) protein expression and expression of its associated targets cyclin D1, survivin and Bcl-xl were significantly (all p<0.001) increased in carcinoma. In carcinomas, STAT3 (p = 0.019) and Bcl-xl (p = 0.001) mRNAs were correlated with lymph node status. Moreover, nuclear P-STAT3 protein expression (active state) was associated with the expression of its target genes Bcl-xl (p = 0.038) and survivin (p = 0.01) as well as with Ki-67 (p = 0.017). By contrast, cytoplasmic UP-STAT was significantly linked to Bcl-xl mRNA (p = 0.024) and protein (p = 0.001) as well as to cytoplasmic survivin protein expression (p = 0.019).
Conclusion: Both inactive (UP-STAT3) and active (P-STAT3) STAT3 proteins are markedly increased in invasive CRCs. This is associated with Bcl-xl and survivin induction, increased proliferation and lymph node metastasis. This study therefore provides the basis for further examination of the prognostic or predictive value of these molecular markers in CRC.
Conflict of interest statement
Competing interests: None declared.
Figures
Similar articles
- Expression of phosphorylated Stat3, cyclin D1 and Bcl-xL in extramammary Paget disease.
Liu HJ, Moroi Y, Masuda T, Yasumoto S, Kokuba H, Imafuku S, Koga T, Tetsuya T, Tu YT, Aburatani H, Furue M, Urabe K. Liu HJ, et al. Br J Dermatol. 2006 May;154(5):926-32. doi: 10.1111/j.1365-2133.2005.06951.x. Br J Dermatol. 2006. PMID: 16634897 - Analysis of signal transducer and activator of transcription 3 (Stat 3) pathway in multiple myeloma: Stat 3 activation and cyclin D1 dysregulation are mutually exclusive events.
Quintanilla-Martinez L, Kremer M, Specht K, Calzada-Wack J, Nathrath M, Schaich R, Höfler H, Fend F. Quintanilla-Martinez L, et al. Am J Pathol. 2003 May;162(5):1449-61. doi: 10.1016/S0002-9440(10)64278-2. Am J Pathol. 2003. PMID: 12707028 Free PMC article. - [Relationship of Stat3 and its target gene products with malignancy in human colorectal carcinoma].
Ma XT, Wang S, Ye YJ, Du RY, Cui ZR. Ma XT, et al. Ai Zheng. 2003 Nov;22(11):1135-9. Ai Zheng. 2003. PMID: 14613639 Chinese. - Prognostic significance of anti-apoptosis proteins survivin and bcl-2 in non-small cell lung carcinomas: a clinicopathologic study of 102 cases.
Kren L, Brazdil J, Hermanova M, Goncharuk VN, Kallakury BV, Kaur P, Ross JS. Kren L, et al. Appl Immunohistochem Mol Morphol. 2004 Mar;12(1):44-9. doi: 10.1097/00129039-200403000-00009. Appl Immunohistochem Mol Morphol. 2004. PMID: 15163019 Review. - Regulation of Bcl-xL: a little bit of this and a little bit of STAT.
Grad JM, Zeng XR, Boise LH. Grad JM, et al. Curr Opin Oncol. 2000 Nov;12(6):543-9. doi: 10.1097/00001622-200011000-00006. Curr Opin Oncol. 2000. PMID: 11085453 Review.
Cited by
- STAT3-iNOS Signaling Mediates EGFRvIII-Induced Glial Proliferation and Transformation.
Puram SV, Yeung CM, Jahani-Asl A, Lin C, de la Iglesia N, Konopka G, Jackson-Grusby L, Bonni A. Puram SV, et al. J Neurosci. 2012 Jun 6;32(23):7806-18. doi: 10.1523/JNEUROSCI.3243-11.2012. J Neurosci. 2012. PMID: 22674257 Free PMC article. - Neuroprotective effects of electroacupuncture on early- and late-stage spinal cord injury.
Wu MF, Zhang SQ, Liu JB, Li Y, Zhu QS, Gu R. Wu MF, et al. Neural Regen Res. 2015 Oct;10(10):1628-34. doi: 10.4103/1673-5374.167762. Neural Regen Res. 2015. PMID: 26692861 Free PMC article. - Critical role of STAT3 in IL-6-mediated drug resistance in human neuroblastoma.
Ara T, Nakata R, Sheard MA, Shimada H, Buettner R, Groshen SG, Ji L, Yu H, Jove R, Seeger RC, DeClerck YA. Ara T, et al. Cancer Res. 2013 Jul 1;73(13):3852-64. doi: 10.1158/0008-5472.CAN-12-2353. Epub 2013 Apr 30. Cancer Res. 2013. PMID: 23633489 Free PMC article. - Analysis of CF patient survival confirms STAT3 as a CF-modifying gene with changing impact over time.
Dunsche I, Raddatz EL, Ismer H, Hedtfeld S, Tamm S, Moser S, Kontsendorn J, Tümmler B, Janciauskiene S, Dittrich AM, Stanke F. Dunsche I, et al. Hum Mol Genet. 2023 Jan 27;32(4):543-550. doi: 10.1093/hmg/ddac221. Hum Mol Genet. 2023. PMID: 36048831 Free PMC article. - Effects of silencing the ATP-binding cassette protein E1 gene by electroporation on the proliferation and migration of EC109 human esophageal cancer cells.
Li XR, Yang LZ, Huo XQ, Wang Y, Yang QH, Zhang QQ. Li XR, et al. Mol Med Rep. 2015 Jul;12(1):837-42. doi: 10.3892/mmr.2015.3512. Epub 2015 Mar 19. Mol Med Rep. 2015. PMID: 25815591 Free PMC article.
References
- Shuai K, Liu B. Regulation of JAK‐STAT signalling in the immune system. Nat Rev Immunol 20033900–911. - PubMed
- Bromberg J, Darnell J E., Jr The role of STATs in transcriptional control and their impact on cellular function. Oncogene 2000192468–2473. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous